Generative AI (Artificial Intelligence) comes with a promise of offering unparalleled opportunities to life sciences organizations. Yet, the success of the journey grips on how data ready is your company for gen AI. From improving drug discovery to enhancing trials and devising marketing strategies, there is a vast potential to take benefit from the use […]
On average, it takes over 10 years and costs upwards of $2.6 billion to get a new drug from initial discovery to approval by regulatory bodies like the FDA. Moreover, processes like clinical trials are long, complex, and expensive that pharmaceutical companies must undertake to test the safety and efficacy of new medical treatments. A […]
Life sciences industry is experiencing its own gen AI revolution resulting in efficient clinical trials, accelerated dug discovery, quicker document summarizations, chatbots taking over repetitive manual tasks, and we are just getting started. When used effectively, gen AI can assist in almost all the departments and stakeholders right from R&D to commercialization of a drug. […]
AI (Artificial Intelligence) is no longer a theory in our textbooks, it is now involved in our day-to-day lives. Health care companies also started to adopt AI as it is quick to analyze data and perform activities which otherwise took days to complete. The explosion of data in healthcare data and the need to make […]
Artificial intelligence is helping organizations all over the world to expand their capabilities. Just ask the Cochrane Transform Project. At i2e Consulting, we want you to have the best tools to increase your abilities.
With Azure, the Cochrane Transform Project–and more than 5,000 citizen scientists around the world–are using artificial intelligence to analyze hundreds of thousands of reports and clinical trials, speeding up the research for cures. All thanks to Azure.
We want you to maximize your data’s potential. Contact us for more.
